Yukihiro Koike
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Effectiveness of direct acting antiviral agents for hepatitis C virus related recurrent hepatocellular carcinoma patients who had multiple courses of recurrence.
Journal: Journal of viral hepatitis
Published: November 30, 2020
Impact of Adverse Events on the Progression-Free Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Retrospective Study.
Journal: Drugs - real world outcomes
Published: February 13, 2020
An open-label phase I/II study of tamibarotene in patients with advanced hepatocellular carcinoma.
Journal: Hepatology international
Published: January 29, 2013
Percutaneous ethanol injection for hepatocellular carcinoma: 20-year outcome and prognostic factors.
Percutaneous ethanol injection for hepatocellular carcinoma: 20-year outcome and prognostic factors.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: April 04, 2012
Impact of radio-frequency ablation for unresectable hepatic metastases
Journal: Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology
Published: October 17, 2009
Changes in hepatic functional reserve after percutaneous tumor ablation for hepatocellular carcinoma: long-term follow up for 227 consecutive patients with a single lesion.
Journal: Hepatology international
Published: June 01, 2007
Factors affecting the prognosis of patients with hepatocellular carcinoma invading the portal vein--a retrospective analysis using 952 consecutive HCC patients.
Journal: Hepato-gastroenterology
Published: December 31, 2003
Showing 1-8 of 8
Last Updated: 09/26/2026